| 6MWD | Distance Walked in a 6 Min Walk Test |
| ASA | American Society of Anesthesiologists |
| COVID: COVID-19 | Coronavirus-Induced Disease 2019 |
| CRP | C-reactive Protein |
| CT | Computed Tomography |
| DBRCT | Double-blind Randomized Clinical Trials |
| DLCO | Diffusing Capacity of the Lungs for Carbon Monoxide |
| ECM | Extracellular Matrix |
| EQ-5D | EuroQol-5 Dimensions Questionnaire |
| FACIT-Dyspnea-10 | Functional Assessment of Chronic Illness Therapy–Dyspnea Questionnaire–10 items |
| FEV1 | Forced Expiratory Volume in 1 s |
| FGF | Fibroblast Growth Factor |
| FVC | Forced Vital Capacity |
| GAD-7 | General Anxiety Disorder-7 score |
| GGO | Ground-Glass Opacity |
| HRV | Heart Rate Variability |
| ICD-10 | 10th revision of the International Statistical Classification of Diseases and Related Health Problems |
| ICU | Intensive Care Unit |
| IL-1 | Interleukin 1 |
| IL-1β | Interleukin 1β |
| IL-6 | Interleukin 6 |
| IL-8 | Interleukin 8 |
| IL-10 | Interleukin 10 |
| IL-13 | Interleukin 13 |
| IL-2R | Interleukin-2 Receptor |
| IPF | Idiopathic Pulmonary Fibrosis |
| KBILD | King’s Brief ILD Questionnaire |
| LPS | Lipopolysaccharide |
| mBDS | Modified Borg Dyspnea Scale |
| MC | Multicenter |
| MMF | Mycophenolate Mofetil |
| mMRC | Modified Medical Research Council |
| NALRP3 | Cryopyrin |
| NF-KB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells |
| Non-RCT | Nonrandomized Controlled Trial |
| Non-RT | Nonrandomized Trial |
| OP | Organizing Pneumonia |
| PBMC | Peripheral Blood Mononuclear Cell |
| PCOP | Post-COVID-19 Organizing Pneumonia |
| PCPS | Post-COVID-19 Pulmonary Sequelae |
| PDGF | Platelet-Derived Growth Factor |
| PHQ-9 | Patient Health Questionnaire-9 |
| PIOP | Postinfection Organizing Pneumonia |
| QD | Once-a-Day |
| QOL-BREF | Quality of Life-BREF Score |
| RAND 36 | Rand 36-item Health Survey |
| RCT | Randomized Controlled Trial |
| RHI | Reactive Hyperemia Index |
| ROS | Reactive Oxygen Species |
| RPE | Borg Rating of Perceived Exertion |
| RR | Risk Ratio |
| SARS | Severe Acute Respiratory Syndrome |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| SBRCT | Single-blind Randomized Clinical Trials |
| SC | Single Center |
| SF-36 | Thirty-Six-Item Short-Form Health Survey questionnaire |
| SGRQ | the St. George’s Respiratory Questionnaire scale |
| SpO2 | Oxygen Saturation |
| TGF-β | Tumor Necrosis Factor Beta |
| TLC | Total Lung Capacity |
| TLCO | Transfer Capacity of the Lung |
| TNF-α | Tumor Necrosis Factor Alpha |
| VAS | Visual Analogue Scale |
| VEGF | Vascular Endothelial Growth Factor |